Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics

Hypertension Research

Volumn 34, Issue 1, 2011, Pages 47-48

  Nishikawa, Tetsuo ^a   Omura, Masao ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; POTASSIUM;

ALDOSTERONE BLOOD LEVEL; BLOOD PRESSURE; HUMAN; JAPANESE; MEDICAL EXAMINATION; NOTE; OUTPATIENT DEPARTMENT; POTASSIUM URINE LEVEL; PREHYPERTENSION; PRIMARY HYPERALDOSTERONISM; SCREENING;

AMBULATORY CARE FACILITIES; BLOOD PRESSURE; HUMANS; HYPERALDOSTERONISM; PHYSICAL EXAMINATION;

EID: 78650856907     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.202     Document Type: Note

References (37)

1. Connell JM. Is there an epidemic of primary hyperal-dosteronism? J Hum Hypertens 2002; 16: 151-152.
2. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary hyperaldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.
3. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary hyperaldosteronism in the Tayside hypertension clinic population. J Hum Hyper-tens 2000; 14: 311-315.
4. Sherwin RP, Conn JW. Present status of pathology of adrenal gland in hypertension. Am J Surg 1964; 107: 136-143.
5. Fishman LM, Kuchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT. Incidence of primary aldosteron-ism uncomplicated 'essential' hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 1968; 205: 497-502.
6. Caplan RH, Strutt PJ, Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 1994; 129: 291-296.
7. Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE. The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum Hypertens 1988; 2: 187-189.
8. Berglund G, Andersson O, Wilhelmsen L. Prevalence of primary and secondary hypertension: studies in a random population sample. BMJ 1976; 2: 554-556.
9. Streeten DH, Tomycz N, Anderson GH. Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403-413.
10. Tucker RM, Labarthe DR. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 1977; 52: 549-555.
11. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289-1293.
12. Schwartz GL, Turner ST. Screening for primary aldos-teronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386-394.
13. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteron-ism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.
14. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-2859.
15. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 855: 1863-1867.
16. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hyper-tens 2000; 14: 311-315.
17. Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42: 161-165.
18. Hamlet SM, Tunny TJ, Woodland E, Gordon RD. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 1985; 12: 249-252.
19. Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Roai Hospital. Biomed Phamacother 2000; 54: 83-85.
20. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202.
21. Naruse M, Tanaka T, Otani S, Ogwa J, Tanabe M, Ishizuka N. PHAS-J Study Group-A study on the frequency of primary aldosteronism in hypertensive patients in Japan using the network of the National Hospital Organization (NHO). Folia Endocrinologica Japonica 2009; 85: 246S.
22. Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and renin-aldosterone system. J Hypertens 1997; 15: 65-72.
23. Committee for the Preparation of Guidelines for the Treatment of Hypertension, Japanese Society of Hypertension. Guidelines for the Treatment of Hypertension 2009. Life Science Publishing: Tokyo, 2009.
24. Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 2011; 34: 98-102
25. Snow MH, Nicol P, Wilkinson R, Hall R, Johnston ID, Hacking PM, Rolland C. Normotensive primary aldos-teronism. BMJ 1976; 1: 1125-1126.
26. Zipser RD, Speckart PF. 'Normotensive' primary aldos-teronism. Ann Intern Med 1978; 88: 655-656.
27. Shiroto H, Ando H, Ebitani I, Hara M, Numazawa K, Kawamura S, Sasaki H. Normotensive primary aldos-teronism. Am J Med 1980; 69: 603-606.
28. Kono T, Ikeda F, Oseko F, Imura H, Tanimura H. Normotensive primary aldosteronism: report of a case. J Clin Endocrinol Metab 1981; 52: 1009-1013.
29. Matsunaga M, Hara A, Song TS, Hashimoto M, Tamori S, Ogawa K, Morimoto K, Pak CH, Kawai C, Yoshida O. Asymptomatic normotensive primary aldoster-onism. Case report. Hypertension 1983; 5: 240-243.
30. Ogihara T, Maruyama A, Hata T, Naka T, Imanaka S, Kumahara Y, Matsumiya K, Ihara H, Koide T, Sagawa S, Saruta T. A zcase of normoreninemic normotensive primary aidosteronism associated with nephrocalc-inosis. Nippon Naikagakkai Zatsushi 1982; 71: 77-82.
31. Nishimiya T, Kikuchi K, Oimatsu H, Ota S, Nakamura Y, Shimamoto K, Iimura O. A case of normotensive primary aldosteronism-comparison with 13 previously experienced cases with hypertension. Endocrinol Jpn 1984; 31: 159-164.
32. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T. Vascular complications in patients with aldos-terone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 1995; 18: 370-373.
33. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261-266.
34. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997; 20: 85-90.
35. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nshi-kawa T. Unique cases of unilateral hyperaldosteronism due to multiple adrenocortical micronodules, which can only be detected by selected adrenal venous sampling. Metabolism 2002; 51: 350-355.
36. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006; 29: 883-889.
37. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res 2007; 30: 1083-1095.